cms.bioaccessla.com

Author: Julio Martinez-Clark

  • ECLA (Estudios Clínicos Latinoamérica) vs a First-in-Human Device CRO (bioaccess®)

    If you typed ECLA (Estudios Clínicos Latinoamérica) into a search box, you are probably building a CRO or site shortlist for Argentina. This article uses only what is public about ECLA (eclainternational.org) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What ECLA publishes

    ECLA describes itself as an organization supporting clinical trials in Latin America since 1987, based in Rosario, Argentina. Its site lists academic leadership, regulatory management, project and site management, monitoring, quality assurance, data management and pharmacy services, with a long record in cardiovascular trials. It is the lead sponsor of the ECLA/PHRI EPIC trial (NCT05638009).

    ECLA vs bioaccess®

    Dimension ECLA bioaccess®
    Core focus Academic research organization, cardiovascular trials First-in-human and early feasibility studies for medical devices
    Geography See provider site Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need academic leadership and coordination for a large cardiovascular trial in Latin America, ECLA’s published services match.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including ECLA, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the local regulatory path, see CRO in Argentina. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the ECLA public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • Idea Médica vs a First-in-Human Device CRO (bioaccess®)

    If you typed Idea Médica into a search box, you are probably building a CRO shortlist. This article uses only what Idea Médica publishes (ideamedica.com.ar) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What Idea Médica publishes

    Idea Médica describes itself as an Argentine holding of healthcare companies founded by physicians more than 30 years ago. It designs and runs turnkey critical medical services for clinics, sanatoriums and hospitals (clinical cardiology, hemodynamics, electrophysiology, nuclear medicine and echocardiography), and also offers strategic communication and medical training. Its scientific research service coordinates clinical trials across medical institutions and links them with the pharmaceutical and biotechnology industry: protocol design and ethics approval, patient recruitment and follow-up, operational coordination and monitoring, and data management and reporting. Its homepage features cardiologist Dr. Álvaro Sosa Liprandi, a former president of the Argentine Society of Cardiology. The current site does not mention medical-device trials.

    Idea Médica vs bioaccess®

    Dimension Idea Médica bioaccess®
    Core focus Argentine cardiology-services holding that coordinates clinical trials First-in-human and early feasibility studies for medical devices
    Geography Argentina (institutions across the country, per its homepage) Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need an Argentine partner that coordinates trials across the cardiology services it manages, Idea Médica is worth a call as a site-side partner.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO on your list, including Idea Médica, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Competitor facts from the Idea Médica public pages linked above and public announcements, reviewed for bioaccess® competitive research (Aug 2026–Nov 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • KLIXAR vs a First-in-Human Device CRO (bioaccess®)

    If you typed KLIXAR into a search box, you are probably building a CRO or site shortlist for Argentina. This article uses only what is public about KLIXAR (www.klixar.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What KLIXAR publishes

    KLIXAR describes itself as a privately owned CRO founded in 2007 in Buenos Aires, with operations in Argentina, Brazil, Colombia and Peru. Its site lists project management, study design and biostatistics, start-up, regulatory affairs, monitoring, outsourcing, investigator training and import/export. It is a listed collaborator on Inmunova INM004 studies (NCT05569746, NCT06389474).

    KLIXAR vs bioaccess®

    Dimension KLIXAR bioaccess®
    Core focus Full-service drug CRO, Argentina First-in-human and early feasibility studies for medical devices
    Geography See provider site Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need an Argentina-based CRO for drug study start-up, monitoring and import, KLIXAR’s published services match.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including KLIXAR, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the local regulatory path, see CRO in Argentina. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the KLIXAR public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • LatinaBA (Blanchard y Asociados) vs a First-in-Human Device CRO (bioaccess®)

    If you typed LatinaBA (Blanchard y Asociados) into a search box, you are probably building a CRO or site shortlist for Argentina. This article uses only what is public about LatinaBA (latinaba.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What LatinaBA publishes

    LatinaBA, formerly Blanchard & Asociados, describes itself as a CRO with more than 16 years in Latin America, headquartered in Argentina with offices in Brazil and Chile and a US contracting office. Its site lists clinical operations, regulatory services, monitoring, medical and protocol writing, observational and RWE studies, clinical trial oversight and medical device research.

    LatinaBA vs bioaccess®

    Dimension LatinaBA bioaccess®
    Core focus Full-service CRO and oversight, Latin America First-in-human and early feasibility studies for medical devices
    Geography See provider site Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need a regional full-service CRO or sponsor oversight for drug trials in Latin America, LatinaBA’s published services match.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including LatinaBA, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the local regulatory path, see CRO in Argentina. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the LatinaBA public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • Synvia vs a First-in-Human Device CRO (bioaccess®)

    If you typed Synvia into a search box, you are probably building a CRO or site shortlist for Brazil. This article uses only what is public about Synvia (synvia.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What Synvia publishes

    Synvia’s Portuguese-language site says it supports the development and registration of medicines through clinical research, bioequivalence, laboratory analysis and integrated digital solutions for the pharmaceutical industry, and describes itself as the largest clinical research company in Latin America. Synvia appears as a study location on ClinicalTrials.gov records for global pharmaceutical sponsors.

    Synvia vs bioaccess®

    Dimension Synvia bioaccess®
    Core focus Clinical research, bioequivalence, lab analysis First-in-human and early feasibility studies for medical devices
    Geography See provider site Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need Phase I, bioequivalence or laboratory capacity for a drug program in Brazil, Synvia’s published services match.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Synvia, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the local regulatory path, see CRO in Brazil. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the Synvia public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • BRCR Global vs a First-in-Human Device CRO (bioaccess®)

    If you typed BRCR Global into a search box, you are probably building a CRO or site shortlist for Brazil. This article uses only what is public about BRCR Global (www.brcrglobal.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What BRCR Global publishes

    BRCR Global is a clinical research organization headquartered in Weston, Florida, with research sites in Florida and a network across Latin America and the Caribbean, including Mexico, Brazil, Peru, Ecuador, Colombia and Costa Rica. Its site lists functional services such as recruitment, start-up, regulatory and legal representation, clinical operations and monitoring, safety, logistics and data operations, with an emphasis on oncology.

    BRCR Global vs bioaccess®

    Dimension BRCR Global bioaccess®
    Core focus FSP and site network across the Americas, oncology emphasis First-in-human and early feasibility studies for medical devices
    Geography See provider site Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need functional-service support or an oncology site network across the Americas, BRCR Global’s published services match.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including BRCR Global, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the local regulatory path, see CRO in Brazil. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the BRCR Global public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • Clinergy Health Research vs a First-in-Human Device CRO (bioaccess®)

    If you typed Clinergy Health Research into a search box, you are probably building a CRO or site shortlist for Brazil. This article uses only what is public about Clinergy Health Research (clinergyhealth.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What Clinergy Health Research publishes

    Clinergy Health Research is a Brazilian CRO in the São Paulo area. Its site describes clinical development, regulatory strategy, site operations and operational support for sites, data analytics, medical writing and scientific support for life-sciences companies in Brazil and Latin America.

    Clinergy Health Research vs bioaccess®

    Dimension Clinergy Health Research bioaccess®
    Core focus Clinical development, regulatory, site support First-in-human and early feasibility studies for medical devices
    Geography See provider site Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need a Brazil-based partner for regulatory strategy and site operations, Clinergy’s published services match.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Clinergy Health Research, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the local regulatory path, see CRO in Brazil. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the Clinergy Health Research public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • Vertex CRO vs a First-in-Human Device CRO (bioaccess®)

    If you typed Vertex CRO into a search box, you are probably building a CRO or site shortlist for Mexico. This article uses only what is public about Vertex CRO (vertexcro.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What Vertex CRO publishes

    Vertex CRO’s Spanish-language site says it accelerates the market entry of medical innovations by connecting science, data, regulation and market access in Latin America, with an emphasis on Mexico and Brazil.

    Vertex CRO vs bioaccess®

    Dimension Vertex CRO bioaccess®
    Core focus Regulatory, data and market entry for medical innovations First-in-human and early feasibility studies for medical devices
    Geography See provider site Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need regulatory and market-entry support for a medical product in Mexico or Brazil, Vertex CRO’s published services match.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Vertex CRO, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the local regulatory path, see CRO in Mexico. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the Vertex CRO public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • H Clinical vs a First-in-Human Device CRO (bioaccess®)

    If you typed H Clinical into a search box, you are probably building a CRO or site shortlist for Mexico. This article uses only what is public about H Clinical (hclinical.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What H Clinical publishes

    H Clinical describes itself as a community-based patient organization that simplifies clinical trials in Latin America, offering home visits, localized infrastructure services, mobile clinics and an integrated research site network for patients, sponsors, CROs and sites.

    H Clinical vs bioaccess®

    Dimension H Clinical bioaccess®
    Core focus Home visits and decentralized trial services First-in-human and early feasibility studies for medical devices
    Geography See provider site Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need home visits or decentralized trial support for patients in Latin America, H Clinical’s published services match.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including H Clinical, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the local regulatory path, see CRO in Mexico. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the H Clinical public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • BCRI (Brazilian Clinical Research Institute) vs a First-in-Human Device CRO (bioaccess®)

    If you typed BCRI (Brazilian Clinical Research Institute) into a search box, you are probably building a CRO or site shortlist for Brazil. This article uses only what is public about BCRI (ClinicalTrials.gov) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What BCRI publishes

    The Brazilian Clinical Research Institute (BCRI) is an academic research organization in São Paulo. On ClinicalTrials.gov it is the lead sponsor of studies such as the COACTION trial with Bayer (NCT06627530) and the COALIZAO ACTION anticoagulation trial run with leading Brazilian hospitals (NCT04394377).

    BCRI vs bioaccess®

    Dimension BCRI bioaccess®
    Core focus Academic research organization, cardiovascular and pragmatic trials First-in-human and early feasibility studies for medical devices
    Geography See provider site Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need an academic research organization for large cardiovascular or pragmatic trials in Brazil, BCRI’s public record matches.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including BCRI, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the local regulatory path, see CRO in Brazil. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the BCRI public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.